Join us as Chris Caldwell, founder of the nonprofit End of Life Psychedelic Care, explains the current federal and state Right to Try legislation and the federal Breakthrough Therapy Act legislation for investigational drugs and its application to expanding access to psychedelic therapies. This webinar illuminates the proposed legislation and other policy reform efforts that could enable patients faced with terminal illnesses to be prescribed investigational treatments to psychedelic medicines. Learn about how you can help move these efforts forward to help access experimental treatments and why these laws matter to the future of psychedelic care and access. 

This educational event is sponsored by Safer Psychedelics Association of New England.